Athersys

11/17/2023

Athersys Reports Third Quarter 2023 Financial Results and Business Highlights

Athersys, Inc. (OTC: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications, announce

10/16/2023

Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives

Athersys, Inc. (Nasdaq: ATHX), (“Athersys” or the “Company”) a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) fo

10/10/2023

Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios

Athersys, Inc. (Nasdaq: ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, a

10/06/2023

We're excited for Alliance for Regenerative Medicine's next week! Looking forward to connecting with senior executives and key stakeholders in the cell and gene therapy industry.

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures.

10/03/2023

Athersys Licenses its Animal Health Assets to Ardent Animal Health

Athersys, Inc. (Nasdaq: ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, a

10/03/2023

We are excited to announce that Jane Wasman, JD, has been appointed Athersys Board Chair. Read more here: https://buff.ly/3F2IxB0

09/28/2023

We hosted our 2023 Annual Meeting of Stockholders yesterday. In case you missed it, you can listen to a replay here -

ATHERSYS, INC.'s meeting has concluded. A replay will be available in 24 hours at: www.virtualshareholdermeeting.com/ATHX2023

09/27/2023

Our Annual Meeting will begin at 8:30 a.m. ET this morning. Stockholders and guests can join beginning now here:

Please complete the required fields below to access the meeting as a stockholder. For assistance, please call Phone number844-986-0822 (US) or Phone number303-562-9302 (International).

09/26/2023

Tomorrow is our Annual Meeting of Stockholders. The meeting will begin at 8:30 a.m. ET. If you're a stockholder, please have your control number ready. Both stockholders and guests can join 15 minutes prior to the start of the meeting.

ATHERSYS, INC. is hosting a Virtual Stockholder Meeting on Wednesday, September 27, 2023 at 08:30 AM, Eastern Time, and the stockholders of record will be able to vote and ask questions online during the meeting. If you would like to attend the virtual meeting and have your control number, please lo...

09/25/2023

The American Stroke Association has a number of great resources for stroke patients and caregivers, including a directory of local support groups. Find the support group nearest to you here: https://buff.ly/3LzV7LP

09/22/2023

Reminder: Our Annual Meeting of the Stockholders is next Wednesday, September 27th at 8:30 a.m. ET. This meeting will be open to both stockholders and guests. If you are a stockholder and wish to vote during the meeting, you will need to join with your control number.

If you have questions in advance of the meeting, please reach out to IR@athersys.com.

The 2023 Annual Meeting of Stockholders will be a virtual meeting and stockholders can participate online at http://www.virtualshareholdermeeting.com/ATHX2023 on September 27, 2023 at 8:30 AM Eastern Time. To attend the Annual Meeting, you will need the 16-digit control number located on your prox...